MaxCyte Appoints Ali Soleymannezhad as Chief Commercial Officer - MaxCyte ( NASDAQ:MXCT )
ROCKVILLE, Md., Oct. 10, 2024 ( GLOBE NEWSWIRE ) -- MaxCyte, Inc., MXCTMXCT ) ) , a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative ...
| Ticker |
Sentiment |
Impact |
|
MXCT
|
Somewhat Bullish
|
25 %
|
|
TOSCF
|
Neutral
|
7 %
|
